Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytek Biosciences Inc. logo

PRESIDENT AND CEO Jiang Wenbin converted options into 45,175 shares and covered exercise/tax liability with 12,656 shares, increasing direct ownership by 0.63% to 5,224,911 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CTKB· Cytek Biosciences Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTKB (Cytek Biosciences Inc.) and more on Quantisnow.